Literature DB >> 36058417

Comparison of inflammatory and behavioral responses to chronic stress in female and male mice.

Eva M Medina-Rodriguez1, Kenner C Rice2, Richard S Jope3, Eléonore Beurel4.   

Abstract

Major depressive disorder (MDD) is a debilitating disease with a high worldwide prevalence. Despite its greater prevalence in women, male animals are used in most preclinical studies of depression even though there are many sex differences in key components of depression, such as stress responses and immune system functions. In the present study, we found that chronic restraint stress-induced depressive-like behaviors are quite similar in male and female mice, with both sexes displaying increased immobility time in the tail suspension test and reduced social interactions, and both sexes exhibited deficits in working and spatial memories. However, in contrast to the similar depressive-like behaviors developed by male and female mice in response to stress, they displayed different patterns of pro-inflammatory cytokine increases in the periphery and the brain, different changes in microglia, and different changes in the expression of Toll-like receptor 4 in response to stress. Treatment with (+)-naloxone, a Toll-like receptor 4 antagonist that previously demonstrated anti-depressant-like effects in male mice, was more efficacious in male than female mice in reducing the deleterious effects of stress, and its effects were not microbiome-mediated. Altogether, these results suggest differential mechanisms to consider in potential sex-specific treatments of depression.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (+)-Naloxone; Depression; Inflammation; Microbiome; Sex differences; Toll-like receptor-4

Mesh:

Substances:

Year:  2022        PMID: 36058417      PMCID: PMC9561002          DOI: 10.1016/j.bbi.2022.08.017

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   19.227


  81 in total

Review 1.  Social functioning in major depressive disorder.

Authors:  Aleksandra Kupferberg; Lucy Bicks; Gregor Hasler
Journal:  Neurosci Biobehav Rev       Date:  2016-07-06       Impact factor: 8.989

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice.

Authors:  Amanda M Dossat; Katherine N Wright; Caroline E Strong; Mohamed Kabbaj
Journal:  Neuropharmacology       Date:  2017-11-21       Impact factor: 5.250

4.  Sex Differences in Effects of Ketamine on Behavior, Spine Density, and Synaptic Proteins in Socially Isolated Rats.

Authors:  Ambalika Sarkar; Mohamed Kabbaj
Journal:  Biol Psychiatry       Date:  2016-01-11       Impact factor: 13.382

5.  GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.

Authors:  M Pardo; E Abrial; R S Jope; E Beurel
Journal:  Genes Brain Behav       Date:  2016-02-12       Impact factor: 3.449

Review 6.  From inflammation to sickness and depression: when the immune system subjugates the brain.

Authors:  Robert Dantzer; Jason C O'Connor; Gregory G Freund; Rodney W Johnson; Keith W Kelley
Journal:  Nat Rev Neurosci       Date:  2008-01       Impact factor: 34.870

Review 7.  Depression as a microglial disease.

Authors:  Raz Yirmiya; Neta Rimmerman; Ronen Reshef
Journal:  Trends Neurosci       Date:  2015-10       Impact factor: 13.837

Review 8.  Sex differences in the effects of social defeat on brain and behavior in the California mouse: Insights from a monogamous rodent.

Authors:  Michael Q Steinman; Brian C Trainor
Journal:  Semin Cell Dev Biol       Date:  2016-06-30       Impact factor: 7.727

9.  Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression.

Authors:  Dag Henrik Reikvam; Alexander Erofeev; Anders Sandvik; Vedrana Grcic; Frode Lars Jahnsen; Peter Gaustad; Kathy D McCoy; Andrew J Macpherson; Leonardo A Meza-Zepeda; Finn-Eirik Johansen
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

Review 10.  Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.

Authors:  Qianquan Ma; Changsheng Xing; Wenyong Long; Helen Y Wang; Qing Liu; Rong-Fu Wang
Journal:  J Neuroinflammation       Date:  2019-03-01       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.